Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study

被引：0
|
作者：
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] EBMT Study Off, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] European Inst Oncol, Milan, Italy
[5] Ctr Leon Berard, F-69373 Lyon, France
[6] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[7] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[8] Erciyes Univ, Kayseri, Turkey
[9] Portuguese Inst Oncol, Oporto, Portugal
[10] Univ Milan, Milan, Italy
[11] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[12] Ist Ospitalieri Cremona, Cremona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15536
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of bevacizumab (BEV)/high-dose chemotherapy (HDC) for refractory germ-cell tumors (GCT).
    Nieto, Yago
    Tannir, Nizar M.
    Tu, Shi-Ming
    Jones, Roy B.
    Zurita, Amado J.
    Aparicio, Ana
    Bassett, Roland
    Margolin, Kim Allyson
    Holmberg, Leona
    Champlin, Richard E.
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Single versus sequential high-dose chemotherapy (HOCT) in patients with relapsed or refractory germ-cell tumors (GCT).
    Lorch, A.
    Rick, O.
    Hartmann, J. T.
    Kollmannsberger, C.
    Metzner, B.
    Schmidt-Wolf, I.
    Berdel, W. E.
    Schirren, R.
    Beyer, J.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 219S - 219S
  • [23] Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts).
    Feldman, Darren Richard
    Voss, Martin Henner
    Jia, Xiaoyu
    Van Alstine, Lindsay Joy
    Patil, Sujata
    Fischer, Patricia
    Sheinfeld, Joel
    Bosl, George J.
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
    Lorch, A.
    Neubauer, A.
    Hackenthal, M.
    Dieing, A.
    Hartmann, J. T.
    Rick, O.
    Bokemeyer, C.
    Beyer, J.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 820 - 825
  • [25] Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
    Taza, Fadi
    Abonour, Rafat
    Zaid, Mohammad Abu
    Althouse, Sandra K.
    Anouti, Bilal
    Akel, Reem
    Hanna, Nasser H.
    Adra, Nabil
    Einhorn, Lawrence H.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 213 - 220
  • [26] High-dose chemotherapy and autotransplantation for patients with extragonadal germ cell tumors: results from the first EBMT registry data analysis.
    Rosti, G
    Ferrante, P
    De Giorgi, U
    Papiani, G
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S42 - S42
  • [27] Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL).
    Feldman, Darren R.
    Lewis, Akeem Ronell
    Knezevic, Andrea
    Ali, David
    Bromberg, Maria
    Aronson, Julia
    Funt, Samuel Aaron
    McHugh, Deaglan Joseph
    Motzer, Robert J.
    Bajorin, Dean F.
    Patil, Sujata
    Shah, Gunjan L.
    Shah, Monika
    Seo, Susan
    Kamboj, Mini
    Perales, Miguel-Angel
    Papanicolaou, Genofeva
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets).
    Kalra, Maitri
    Adra, Nabil
    Mckay, John
    Abonour, Rafat
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] FDG-PET for the evaluation of high-dose chemotherapy (HD-CTX) in patients with metastatic germ cell tumors (GCT)
    Bokemeyer, G
    Kollmannsberger, O
    Sokler, W
    Dohmen, BM
    Oechsle, K
    Hartmann, JT
    Pfannenberg, AC
    Bares, R
    Kanz, L
    ANNALS OF ONCOLOGY, 1998, 9 : 56 - 56
  • [30] Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)
    Adra, Nabil
    Althouse, Sandra K.
    Abonour, Rafat
    Abu Zaid, Mohammad Issam
    Liu, Hao
    Hanna, Nasser H.
    Einhorn, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345